Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit – PR Newswire (press release)
|
Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit
PR Newswire (press release) BUFFALO, N.Y., May 29, 2018 /PRNewswire-USNewswire/ — The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at the 2018 American Society of Clinical … |
